-+ 0.00%
-+ 0.00%
-+ 0.00%

Barrington Research Maintains Outperform on OPKO Health, Lowers Price Target to $1.5

Benzinga·03/02/2026 15:44:45
Listen to the news
Barrington Research analyst Michael Petusky maintains OPKO Health (NASDAQ:OPK) with a Outperform and lowers the price target from $2.25 to $1.5.